Skip to content

Contacts

FacebookTwitter
  • Italian
  • English
FisIm Ematologia
FisIm Ematologia
FISiM
  • HOME
  • CHI SIAMO
    • Scopi
    • Struttura
    • Statuto
  • MDS e TERAPIE
    • Le Mielodisplasie
      • Cosa sono le Mielodisplasie
      • Le cause
      • I sintomi
      • Gli esami diagnostici
      • La classificazione dellle MDS
      • I sistemi prognostici
    • Terapie
      • Osservazione
      • Terapie secondo pratica clinica
      • Terapie sperimentali
    • MDS/MPN
    • Terapie per le MDS/MPN
  • CENTRI
  • REGISTRO
  • RICERCA
    • Harmony
    • Harmony plus
    • Progetti di Ricerca
      • Studi in corso
        • FISM-IRON-MDS
        • FISiM-NGS-MDS
      • Studi chiusi
        • FISM-hMDS
        • GFM-DAC-CMML
        • FISM-BIOFER12
        • AISSM06 DECI2009
        • MDS ATO-AISSM02A
    • Pubblicazioni
  • CONGRESSI E EVENTI
    • Congressi FISiM
    • Eventi Patrocinati
  • NOTIZIE
  • COSA PUOI FARE
    • Dona online
    • Dona tramite bonifico bancario
    • Donazione in Memoria
    • Donazione Ricorrente
    • 5 x 1000
    • Agevolazioni Fiscali
  • CONTATTI
  • HOME
  • CHI SIAMO
    • Scopi
    • Struttura
    • Statuto
  • MDS e TERAPIE
    • Le Mielodisplasie
      • Cosa sono le Mielodisplasie
      • Le cause
      • I sintomi
      • Gli esami diagnostici
      • La classificazione dellle MDS
      • I sistemi prognostici
    • Terapie
      • Osservazione
      • Terapie secondo pratica clinica
      • Terapie sperimentali
    • MDS/MPN
    • Terapie per le MDS/MPN
  • CENTRI
  • REGISTRO
  • RICERCA
    • Harmony
    • Harmony plus
    • Progetti di Ricerca
      • Studi in corso
        • FISM-IRON-MDS
        • FISiM-NGS-MDS
      • Studi chiusi
        • FISM-hMDS
        • GFM-DAC-CMML
        • FISM-BIOFER12
        • AISSM06 DECI2009
        • MDS ATO-AISSM02A
    • Pubblicazioni
  • CONGRESSI E EVENTI
    • Congressi FISiM
    • Eventi Patrocinati
  • NOTIZIE
  • COSA PUOI FARE
    • Dona online
    • Dona tramite bonifico bancario
    • Donazione in Memoria
    • Donazione Ricorrente
    • 5 x 1000
    • Agevolazioni Fiscali
  • CONTATTI

FISiM purposes is to advance scientific research and treatment of myelodysplastic syndromes by fighting side by side with patients against this disease.

This is the cornestone  around which the daily activity of the Foundation revolve: scientific research as a continuous, all-encompassing study of the disease.

FISiM has a case history of nearly 5000 patients that is constantly used to find new  useful information in order to extend the knowledge about MDS and their biological aspects and to contribute to the study of new therapeutic solutions.

These activities also aim to improve the everyday lives of patients: finding innovative care means focusing on treatments that don’t require hospitalization or that allow patients not to spend the whole day at an outpatients clinic. The support of the family and the peace of their own home are in fact very important aspects that help the patients during the illness.

FISiM strongly believes in research intended as participation in clinical trials ( in which often it has the role of sponsor): the access to an experimental protocol means having effective therapies available that at the moment are not included in the “routine” of the National Health System.

The work of FISiM is based on ethical research, perseverance and the conviction that it is possible to make a difference in the fight against myelodysplasia.

News
  • October 25, MDS World Awareness Day
    26 October 2018
  • Defeating anaemia in myelodysplastic syndromes: another step forward with Luspatercept
    16 October 2017
  • Prof. Valeria Santini, FISM President, talks about Myelodysplastic Syndromes in this video realized by Aplastic Anemia & MDS Foundation
    13 October 2017
FisIm Ematologia
FISiM – Fondazione Italiana Sindromi Mielodiplastiche – ETS - C.F.: 96039720063 | Partita IVA: 02179990060

Policy Privacy